MANFREDINI, Rossella
 Distribuzione geografica
Continente #
NA - Nord America 17.622
AS - Asia 8.425
EU - Europa 8.037
SA - Sud America 1.197
AF - Africa 215
OC - Oceania 51
Continente sconosciuto - Info sul continente non disponibili 20
Totale 35.567
Nazione #
US - Stati Uniti d'America 17.334
GB - Regno Unito 2.553
SG - Singapore 2.384
CN - Cina 2.081
IT - Italia 1.657
HK - Hong Kong 1.335
VN - Vietnam 986
SE - Svezia 943
BR - Brasile 890
DE - Germania 617
FI - Finlandia 419
RU - Federazione Russa 416
FR - Francia 401
KR - Corea 347
UA - Ucraina 274
TR - Turchia 256
IN - India 199
CA - Canada 170
ID - Indonesia 157
BG - Bulgaria 120
BD - Bangladesh 111
NL - Olanda 106
AR - Argentina 99
MX - Messico 77
PL - Polonia 75
IQ - Iraq 74
JP - Giappone 73
SI - Slovenia 68
ZA - Sudafrica 65
PK - Pakistan 61
BE - Belgio 53
CO - Colombia 50
EC - Ecuador 48
AU - Australia 47
ES - Italia 47
IE - Irlanda 46
IR - Iran 42
LT - Lituania 40
KE - Kenya 37
CL - Cile 36
SA - Arabia Saudita 36
AE - Emirati Arabi Uniti 35
CZ - Repubblica Ceca 33
MA - Marocco 29
UZ - Uzbekistan 28
MY - Malesia 27
AT - Austria 24
PH - Filippine 24
TW - Taiwan 24
VE - Venezuela 21
DZ - Algeria 20
EG - Egitto 20
CH - Svizzera 19
TN - Tunisia 19
IL - Israele 18
NP - Nepal 16
PY - Paraguay 16
QA - Qatar 16
BO - Bolivia 15
PT - Portogallo 15
EU - Europa 13
AL - Albania 12
RO - Romania 12
PE - Perù 11
AZ - Azerbaigian 10
DK - Danimarca 10
GR - Grecia 10
TH - Thailandia 10
JM - Giamaica 9
RS - Serbia 9
HU - Ungheria 8
JO - Giordania 8
OM - Oman 8
UY - Uruguay 8
KG - Kirghizistan 7
LU - Lussemburgo 7
MN - Mongolia 7
BH - Bahrain 6
DO - Repubblica Dominicana 6
NO - Norvegia 6
PS - Palestinian Territory 6
AM - Armenia 5
BY - Bielorussia 5
CR - Costa Rica 5
EE - Estonia 5
KZ - Kazakistan 5
MD - Moldavia 5
NI - Nicaragua 5
SK - Slovacchia (Repubblica Slovacca) 5
SN - Senegal 5
TT - Trinidad e Tobago 5
GE - Georgia 4
HR - Croazia 4
KH - Cambogia 4
KW - Kuwait 4
NG - Nigeria 4
XK - ???statistics.table.value.countryCode.XK??? 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BA - Bosnia-Erzegovina 3
GY - Guiana 3
Totale 35.515
Città #
Southend 1.849
Ashburn 1.813
Fairfield 1.588
Santa Clara 1.519
Singapore 1.455
Hong Kong 1.301
Chandler 1.015
Woodbridge 978
Houston 740
San Jose 737
Seattle 618
Ann Arbor 555
Wilmington 540
Cambridge 528
Nyköping 514
Hefei 501
Beijing 454
Jacksonville 434
Chicago 402
Dearborn 399
London 376
Los Angeles 352
Seoul 316
Modena 313
Ho Chi Minh City 299
Helsinki 286
Council Bluffs 248
Hanoi 220
The Dalles 206
New York 198
Salt Lake City 186
San Diego 165
Munich 128
Izmir 127
Princeton 123
Sofia 117
Jakarta 112
Milan 109
Shanghai 107
Buffalo 99
Lauterbourg 97
Bologna 93
São Paulo 90
Moscow 87
Tampa 87
Dallas 86
Eugene 86
Fremont 72
Elk Grove Village 67
Des Moines 64
Frankfurt am Main 64
Orem 63
Bremen 53
Reggio Emilia 53
Montreal 52
Rome 52
Tokyo 52
Turku 52
Da Nang 50
Warsaw 47
Brussels 46
Redwood City 44
Falls Church 43
Shenzhen 43
Dublin 42
Haiphong 41
Phoenix 41
Miami 40
Toronto 40
Sterling 38
Lancaster 37
Nuremberg 37
Falkenstein 36
Denver 35
Hillsboro 32
Boardman 31
Chennai 31
Columbus 31
Dong Ket 31
Johannesburg 31
Manchester 30
Ottawa 30
Parma 29
Atlanta 28
Brooklyn 28
Biên Hòa 27
Mexico City 27
Nairobi 27
Sant'Ilario d'Enza 25
Amsterdam 24
Florence 24
Rio de Janeiro 24
Baghdad 23
Detroit 23
Guangzhou 23
Tashkent 23
Brasília 22
Palermo 22
Paris 22
Poplar 22
Totale 24.647
Nome #
Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms 553
c-Myb supports erythropoiesis through the transactivation of KLF1 and LMO2 expression. 500
c-Myb supports erythropoiesis by transactivating KLF1 and LMO2 expression 463
Implementation of an NGS-based workflow for BRCA1 and BRCA2 mutation screening 455
miR-382-5p Controls Hematopoietic Stem Cell Differentiation Through the Downregulation of MXD1 428
Virally mediated MafB transduction induces the monocyte commitment of human CD34+ hematopoietic stem/progenitor cells 418
Involvement of MAF/SPP1 axis in the development of bone marrow fibrosis in PMF patients 418
C-Myb Restrains Megakaryopoiesis through the Hsa-MiR-486-3p-Driven Down-Regulation of C-Maf 415
Bone marrow-derived hematopoietic cells undergo myogenic differentiation following a Pax-7 independent pathway 414
Deregulated expression of miR-29a-3p, miR-494-3p and miR-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cells 407
Purinergic signaling inhibits human acute myeloblastic leukemia cell proliferation, migration, and engraftment in immunodeficient mice 400
Unravelling the Complexity of Inherited Retinal Dystrophies Molecular Testing: Added Value of Targeted Next-Generation Sequencing 389
Correlation between differentiation plasticity and mRNA expression profiling of CD34+-derived CD14- and CD14+ human normal myeloid precursors 388
The extracellular nucleotide UTP is a potent inducer of hematopoietic stem cell migration 384
Co-culture of hematopoietic stem/progenitor cells with human osteblasts favours mono/macrophage differentiation at the expense of the erythroid lineage 378
Eosinophils, but not neutrophils, exibit an efficient DNA repair machinary and high nucleolar activity 372
Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms' tumor gene 1 (WT1) 366
MicroRNA expression profile in granulocytes from primary myelofibrosis patients 365
miR-494-3p overexpression promotes megakaryocytopoiesis in primary myelofibrosis hematopoietic stem/progenitor cells by targeting SOCS6 362
Amplicon-based Next Generation Sequencing: an effective approach to molecular diagnosis of Epidermolysis Bullosa 360
Calreticulin Ins5 and Del52 mutations impair unfolded protein and oxidative stress responses in K562 cells expressing CALR mutants 359
Mutations and prognosis in primary myelofibrosis 356
Transcriptional profiles in melanocytes from clinically unaffected skin distinguish the neoplastic growth pattern in patients with melanoma 356
Genomic landscape of megakaryopoiesis and platelet function defects 354
Integrative Analysis Of mRNA/miRNA Expression Profiles Identified JARID2 As a Shared Target Of Deregulated Mirnas In Primary Myelofibrosis 352
The kinetic status of hematopoietic stem cell subpopulations underlies a differential expression of genes involved in self-renewal, commitment, and engraftment. 351
Molecular profile of CD34+ stem/progenitor cells according to JAK2V617F mutation status in essential thrombocythemia. 349
Amplicon-based next-generation sequencing: an effective approach for the molecular diagnosis of epidermolysis bullosa 346
CALR mutational status identifies different disease subtypes of essential thrombocythemia showing distinct expression profiles 344
miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells: role of miR-155/JARID2 axis in abnormal megakaryopoiesis 342
Antisense inhibition of c-fes proto-oncogene blocks PMA-induced macrophage differentiation in HL60 and in FDC-P1/MAC-11 cells 341
Analytic and Dynamic Secretory Profile of Patient-Derived Cytokine-Induced Killer Cells 341
Identification of a molecular signature predictive of sensitivity to differentiation induction in acute myeloid leukemia 340
Calreticulin affects hematopoietic stem/progenitor cell fate by impacting erythroid and megakaryocytic differentiation 339
Epidemiology and clinical relevance of mutations in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 359 patients of the AGIMM group 337
Role of miR-34a-5p in Hematopoietic Progenitor Cells Proliferation and Fate Decision: Novel Insights into the Pathogenesis of Primary Myelofibrosis 334
Requirement of the coiled-coil domains of p92(c-Fes) for nuclear localization in myeloid cells upon induction of differentiation 327
Role of TGF-β1/miR-382-5p/SOD2 axis in the induction of oxidative stress in CD34+ cells from primary myelofibrosis 326
Abnormal expression patterns of WT1-as, MEG3 and ANRIL long non-coding RNAs in CD34+ cells from patients with primary myelofibrosis and their clinical correlations 323
Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study 322
Purinergic stimulation of human mesenchymal stem cells potentiates their chemotactic response to CXCL12 and increases the homing capacity and production of proinflammatory cytokines 320
Preclinical study for treatment of hypospadias by advanced therapy medicinal products 319
Monocyte Distribution Width (MDW) as novel inflammatory marker with prognostic significance in COVID-19 patients 319
Valproic acid triggers erythro/megakaryocyte lineage decision through induction of GFI1B and MLLT3 expression 314
Gene expression profile of vitamin D3 treated HL60 cells shows an incomplete molecular phenotypic conversion to monocytes 313
A data-driven network model of primary myelofibrosis: transcriptional and post-transcriptional alterations in CD34+ cells 313
Isolation of human keratinocyte stem cells and high-throughput screening approach for their characterization 311
A functionally active RAR alpha nuclear receptor is expressed in retinoic acid non responsive early myeloblastic cell lines 307
Impact Of Prognostically Detrimental Mutations (ASXL1, EZH2, SRSF2, IDH1/2) On Outcomes In Patients With Myelofibrosis Treated With Ruxolitinib In COMFORT-II 295
Extracellular purines promote the differentiation of human bone marrow-derived mesenchymal stem cells to the osteogenic and adipogenic lineages 285
Differential proteomic profile of leukemic CD34+ progenitor cells from chronic myeloid leukemia patients 283
Expression And Function Of Nerve Growth-Factor And Nerve Growth-Factor Receptor On Cultured Keratinocytes. 282
Development of an IL-6 antagonist peptide that induces apoptosis in IL-6 dependent 7TD1 cells. 281
Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12low/neg accessory cells with dendritic-cell features 278
Antiapoptotic effect of c-fes protooncogene during granulocytic differentiation 277
Bone marrow-specific loss of ABI1 induces myeloproliferative neoplasm with features resembling, human myelofibrosis 275
AMPLICON-BASED NGS: AN EFFECTIVE APPROACH FOR THE MOLECULAR DIAGNOSIS OF EPIDERMOLYSIS BULLOSA 273
Wnt/CTNNB1 signal transduction pathway inhibits the expression of ZFP36 in squamous cell carcinoma, by inducing transcriptional repressors SNAI1, SLUG and TWIST 270
Terminal differentiation 268
Role of CD34 antigen in myeloid differentiation of human hematopoietic progenitor cells 267
IDENTIFICATION OF A MOLECULAR SIGNATURE PREDICTIVE OF REFRACTORINESS IN ACUTE MYELOID LEUKEMIA 264
The isopeptidase inhibitor 2cPE triggers proteotoxic stress and ATM activation in chronic lymphocytic leukemia cells 263
ANTISENSE STRATEGIES TO CHARACTERIZE THE ROLE OF GENES AND ONCOGENES INVOLVED IN MYELOID DIFFERENTIATION 261
Mutated clones driving leukemic transformation are already detectable at the single-cell level in CD34-positive cells in the chronic phase of primary myelofibrosis 260
Molecular and functional analysis of the stem cell compartment of chronic myelogenous leukemia reveals the presence of a CD34- cell population with intrinsic resistance to imatinib 259
All-trans-retinoic acid induces simultaneously granulocytic differentiation and expression of inflammatory cytokines in HL-60 cells 257
Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis 257
IDENTIFICATION OF A MOLECULAR SIGNATURE PREDICTIVE OF REFRACTORINESS IN ACUTE MYELOID LEUKEMIA 254
Characterisation and discovery of novel miRNAs and moRNAs in JAK2V617F mutated SET2 cells 253
Chromosome 9p trisomy increases stem cells clonogenic potential and fosters T-cell exhaustion in JAK2-mutant myeloproliferative neoplasms 251
Molecular and functional characterization of CD133+ stem/progenitor cells infused in patients with end-stage liver disease reveals their interplay with stromal liver cells 251
BTK Inhibitors Impair Platelet-Mediated Antifungal Activity 250
Expression of B7 costimulatory molecule in cultured human epidermal Langerhans cells is regulated at the mRNA level. 248
Genomic analysis of hematopoietic stem cell at the single-cell level: Optimization of cell fixation and whole genome amplification (WGA) protocol 244
Presence of a functional vitamin D receptor does not correlate with vitamin D3 phenotypic effects in myeloid differentiation 242
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 240
The Response to Oxidative Damage Correlates with Driver Mutations and Clinical Outcome in Patients with Myelofibrosis 232
Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model 232
Characterization of new ATM deletion associated with hereditary breast cancer 231
Antisense strategies in leukemias 226
Chromosome 9p Duplication Promotes T-Cell Exhaustion and Enhances Stem Cell Clonogenic Potential in JAK2-Mutant Myeloproliferative Neoplasms 221
ROLE OF C-FES PROTOONCOGENE IN MYELOID DIFFERENTIATION 221
SOX2 Is a Univocal Marker for Human Oral Mucosa Epithelium Useful in Post-COMET Patient Characterization 220
Cytokine-induced killer cells express CD39, CD38, CD203a, CD73 ectoenzymes and P1 adenosinergic receptors 217
Gene Expression profile of Vitamin D3 treated HL60 cells shows a phenotypic but not a complete functional conversion to monocytes 216
Automated capture-based NGS workflow: one thousand patients experience in a clinical routine framework 215
Distribution of different classes of CSF3R mutations and co-mutational pattern in 360 myeloid neoplasia 214
Mechanistic insight into WEB-2170-induced apoptosis in human acute myelogenous leukemia cells. the crucial role of PTEN. 214
The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: An international study of 797 patients 209
Novel Molecular Insights into Leukemic Evolution of Myeloproliferative Neoplasms: A Single Cell Perspective 207
Inhibition of c-fes expression by an antisense oligomer causes apoptosis oh HL60 cells induced to granulocytic differentiation 206
Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: Pathogenetic insight and diagnostic value 205
Tie2 expressing monocytes in the spleen of patients with primary myelofibrosis 204
Prognostic Relevance of Multi-Antigenic Myeloma-Specific T-Cell Assay in Patients with Monoclonal Gammopathies 203
Physiological levels of 1 alpha, 25 di-hydroxyvitamin D3 induce the monocytic commitment of CD34+ hematopoietic progenitors 202
Ivar, an interpretation‐oriented tool to manage the update and revision of variant annotation and classification 201
Neoantigen-specific T-cell immune responses: The paradigm of NPM1-mutated acute myeloid leukemia 200
Integrative analysis of copy number and gene expression data suggests novel pathogenetic mechanisms in primary myelofibrosis 199
ANTISENSE STRATEGIES IN LEUKEMIA 195
Increased Plasma Levels of lncRNAs LINC01268, GAS5 and MALAT1 Correlate with Negative Prognostic Factors in Myelofibrosis 194
Totale 30.062
Categoria #
all - tutte 138.478
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 138.478


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021894 0 0 0 0 0 0 0 0 0 429 269 196
2021/20222.630 136 228 299 162 124 153 137 151 265 196 430 349
2022/20233.118 379 406 297 272 333 409 67 284 345 44 143 139
2023/20242.073 81 91 171 177 325 177 303 252 41 72 117 266
2024/20256.651 178 65 120 395 1.226 933 603 449 741 287 827 827
2025/202611.514 807 473 882 1.510 2.356 832 1.583 625 1.244 1.202 0 0
Totale 35.810